Middle Meningeal Artery Embolization (MMAE) is an advanced, minimally invasive procedure used to treat chronic subdural hematomas (cSDH)—a condition where blood accumulates between the brain and its outer membrane, often due to minor head trauma or age-related changes.
Traditionally, cSDH required surgical drainage, especially in elderly patients or those with repeated bleeds. MMAE offers a non-surgical alternative by targeting the blood vessels feeding the hematoma and sealing them off to stop recurrence and promote reabsorption of the clot.
At CARE CHL Hospital, Indore, Dr. Alok K. Udiya performs MMAE with high success, offering patients a safer, faster recovery option—especially valuable for high-risk or elderly patients.
Key Benefits of the Treatment
- Minimally Invasive: Done via a small puncture in the groin or wrist—no brain surgery required.
- Shorter Recovery: No stitches, no craniotomy, faster return to normal life.
- Prevents Recurrence: Targets the cause of re-bleeding by blocking feeder vessels.
- Safe for Elderly & High-Risk Patients: No need for general anesthesia or ICU stay.
- Can Be Used Alone or After Surgery: Effective as primary treatment or as a preventive step after surgery.
How This Treatment Works
1. Diagnosis and Planning
- Confirmed by CT or MRI brain scan
- Suitable for patients with:
- Chronic subdural hematomas
- Recurrence after prior surgery
- Symptoms like headaches, confusion, weakness
2. Procedure
- A microcatheter is advanced into the middle meningeal artery under X-ray guidance.
- Embolic material is injected to block blood flow to the membrane feeding the hematoma.
- Entire procedure takes about 45–60 minutes.
3. Post-Procedure
- Observation for a few hours
- Most patients discharged in 24–48 hours
- Follow-up CT scan after 1–2 months
Why Choose Dr. Alok K. Udiya?
- Among the few in India to offer MMAE for chronic subdural hematoma
- Extensive experience in neurovascular embolisation
- Ideal for patients with recurrence or contraindications to surgery
FAQs
Q1. Is MMAE safe?
Yes, especially when performed by an experienced neurointerventionalist.
Q2. How soon can I recover?
Most patients resume daily activity within 2–3 days.
Q3. Will the clot dissolve?
Yes, over weeks to months, the body reabsorbs the hematoma as blood supply is cut off.
Q4. Is surgery still needed?
Only in cases with large pressure or emergencies. MMAE often prevents surgery.
Q5. Is this covered under insurance?
Yes, it is included in neurointervention packages.